1E Therapeutics
1E Therapeutics is a breakthrough, drug development company.
1E Therapeutics is active in the alternative medicine, biotechnology, medical, therapeutics space based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2020.
Within the alternative medicine, biotechnology, medical, therapeutics space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA).
It is recorded at the Seed stage.
Its team size is recorded as c_00101_00250 employees.
Total disclosed funding stands at about $120M.
| Sector | Alternative Medicine, Biotechnology, Medical, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2020 |
| Employees | c_00101_00250 |
| Stage | seed |
| Total funding | $120,000,000 |
Website: www.1etx.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account